First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUNA trial.

Authors

null

Eric Baudin

Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Campus, Villejuif, France

Eric Baudin , Alfredo Berruti , Mario Giuliano , Wasat Mansoor , Catalin Bobirca , Erik Houtsma , Niamh Fagan , Kjell E. Oberg , Piero Ferolla

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Thymic Malignancies

Clinical Trial Registration Number

NCT01563354

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 8574)

DOI

10.1200/JCO.2021.39.15_suppl.8574

Abstract #

8574

Poster Bd #

Online Only

Abstract Disclosures